Physician profile
Mark A Maraman
NPI 1457559072
$3,802.73
in general payments reported to CMS, 2019-2025
14 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $63.20 · 2021: $3,074 · 2022: $98.02 · 2023: $122 · 2024: $183 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $535 · Honoraria: $32.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $535.18 |
| Honoraria | $32.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $3,073.52 | 2021 | |
| Alcon Vision LLC | $155.11 | 2022-2025 | Clareon, Clareon Panoptix Pro, Hydrus Microstent |
| Glaukos Corporation | $102.06 | 2023-2025 | Idosetr, Istent Infinite, Idose |
| Rxsight INC | $89.30 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $78.47 | 2019-2025 | Tecnis Iol |
| Abbvie INC. | $55.33 | 2022-2024 | |
| Amgen INC. | $46.10 | 2024 | |
| Rayner Intraocular Lenses Limited | $44.95 | 2024-2025 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
| Sight Sciences, INC. | $40.84 | 2022 | |
| Bausch & Lomb Americas INC. | $37.87 | 2023-2025 | Envista Envy Iol, Envista Mx60 Iol |
| Biotissue Holdings INC. | $26.32 | 2025 | |
| Oyster Point Pharma, INC. | $22.16 | 2022 | |
| Eyevance Pharmaceuticals LLC | $16.50 | 2019 | |
| Aerie Pharmaceuticals, INC. | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Maraman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.